Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 18;29(12):534–539. doi: 10.1002/clc.20

Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies

Fabrice Extramiana 1,✉, Pierre Maison‐Blanche 1, Abdeddayem Haggui 1, Fabio Badilini 2, Philippe Beaufils 1, Antoine Leenhardt 1
PMCID: PMC6654636  PMID: 17190179

Abstract

Background

Following an abrupt change in heart rate (HR), QT adaptation is achieved within a delayed time frame.

Hypothesis

The exclusion of electrocardiograms (ECGs) showing rapid HR changes influences the level of a drug‐induced QT prolongation.

Methods

Continuous 12‐lead ECG‐Holter monitoring was performed in 31 healthy subjects. Using the “bin” method, we evaluated moxifloxacin effects on (1) QT interval duration at different RR intervals and (2) on the rate dependence of QT interval. These endpoints were calculated separately for five types of ECG analysis: classification of cardiac complexes based on (a) the single preceding RR interval (RR‐1) and (b) RR filters excluding rapid HR changes according to the formula RR‐1 = RR[time–window] ± threshold, where the time‐window could be 30 or 60 s (R30 and R60) and the threshold 15 or 30 ms (th15 or th30).

Results

Moxifloxacin‐induced QT prolongation was consistently higher using the stable models when compared with the RR‐1 model. Moxifloxacin‐induced QT prolongation at RR = 1000 ms was 8.2 ± 11.2 vs. 10.9 ± 10.4 ms using the RR‐1 and R60th15 stable models, respectively (p < 0.05). Moxifloxacin‐induced QT prolongation was more pronounced at slow than at fast HR. This so‐called “reverse rate‐dependent” effect was more pronounced when assessed using stable HR models (0.023 IC95% [0.019;0.027] vs. 0.015 IC95% [0.012;0.017] using the RR‐1 model).

Conclusion

The exclusion of ECGs with rapid HR changes influences the magnitude of drug‐induced QT changes. The hysteresis phenomenon should not be neglected when dedicated QT studies are performed. Copyright © 2006 Wiley Periodicals, Inc. Wiley Periodicals, Inc.

Keywords: electrocardiogram, Holter, QT interval, hysteresis, moxifloxacin

Full Text

The Full Text of this article is available as a PDF (216.7 KB).

REFERENCES

  • 1. Crouch MA, Limon L, Cassano AT: Clinical relevance and management of drug‐related QT interval prolongation. Pharmacotherapy 2003; 23: 881–908. [DOI] [PubMed] [Google Scholar]
  • 2. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, et al: Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351: 1089–1096. [DOI] [PubMed] [Google Scholar]
  • 3. Moss AJ, Zareba W, Benhorin J, Couderc JP, Kennedy H, et al: ISHNE guidelines for electrocardiographic evaluation of drug‐related QT prolongation and other alterations in ventricular repolarization. Ann Noninvas Electrocardiol 2001; 6: 333–341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Franz MR, Swerdlow CD, Liem LB, Schaefer J: Cycle length dependence of human action potential duration in vivo: Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady state frequency. J Clin Invest 1988; 82: 972–979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Viitasalo M, Karjalainen J: QT Intervals at heart rates from 50 to 120 beats per minute during 24‐hour electrocardiographic recordings in 100 healthy men. Circulation 1992; 86: 1439–1442. [DOI] [PubMed] [Google Scholar]
  • 6. Funck‐Brentano C, Jaillon P: Rate‐corrected QT interval: Techniques and limitations. Am J Cardiol 1993; 72: 17B–22B. [DOI] [PubMed] [Google Scholar]
  • 7. Malik M: The imprecision in heart rate correction may lead to artificial observations of drug‐induced QT interval changes. PACE 2002; 25: 209–216. [DOI] [PubMed] [Google Scholar]
  • 8. Hnatkova K, Malik M: “Optimum” formulae for heart rate correction of the QT interval. PACE 1999; 22: 1683–1687. [DOI] [PubMed] [Google Scholar]
  • 9. Malik M, Farbom P, Batchvarov V, Hnatkova K, Camm AJ: Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval. Heart 2002; 87: 220–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Badilini F, Maison‐Blanche P, Childers R, Coumel P: QT interval analysis on ambulatory electrocardiogram recordings: A selective beat averaging approach. Med Biol Eng Comput 1998; 36: 1–10. [DOI] [PubMed] [Google Scholar]
  • 11. Lande G, Maison‐Blanche P, Fayn J, Ghadanfar M, Coumel P, et al: Dynamic analysis of dofetilide‐induced changes in ventricular repolarization. Clin Pharmacol Ther 1998; 64: 312–321. [DOI] [PubMed] [Google Scholar]
  • 12. Badilini F, Maison‐Blanche P: Holter monitoring for QT: The RR bin method in depth In Cardiac Safety of Noncardiac Drugs (Eds. Morganroth J, Gussak I.). Totowa, New Jersey: Humana Press, 2004. [Google Scholar]
  • 13. Extramiana F, Maison‐Blanche P, Cabanis MJ, Ortemann‐Renon C, Beaufils P, et al: Clinical assessment of drug‐induced QT prolongation when associated with heart rate changes. Clin Pharmacol Ther 2005; 77: 247–258. [DOI] [PubMed] [Google Scholar]
  • 14. Seed WA, Noble MI, Oldershaw P, Wanless RB, Drake‐Holland AJ, et al: Relation of human cardiac action potential duration to the interval between beats: Implications for the validity of rate corrected QT interval (QTc). Br Heart J 1987; 57: 32–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lau CP, Freedman AR, Fleming S, Malik M, Camm AJ, et al: Hysteresis of ventricular paced QT interval in response to abrupt changes in pacing rate. Cardiovasc Res 1988; 22: 67–72. [DOI] [PubMed] [Google Scholar]
  • 16. Extramiana F, Maison‐Blanche P, Tavernier R, Jordaens L, Leenhardt A, et al: Cardiac effects of chronic oral beta‐blockade: Lack of agreement between heart rate and QT interval changes. Ann Noninvas Electrocardiol 2002; 7: 379–388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Extramiana F, Denjoy I, Badilini F, Chabani I, Neyroud N, et al: Heart rate influences on repolarization duration and morphology in symptomatic and asymptomatic KCNQ1 mutation carriers. Am J Cardiol 2005; 95: 406–409. [DOI] [PubMed] [Google Scholar]
  • 18. Pueyo E, Smetana P, Caminal P, de Luna AB, Malik M, et al: Characterization of QT interval adaptation to RR interval changes and its use as a risk‐stratifier of arrhythmic mortality in amiodarone‐treated survivors of acute myocardial infarction. IEEE Trans Biomed Eng 2004; 51: 1511–1520. [DOI] [PubMed] [Google Scholar]
  • 19. International Conference on Harmonisation (ICH) : The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non‐antiarrhythmic Drugs ICH E14, Step 4, May 12, 2005.; http://www.emea.eu.int/pdfs/humanich/000204en.pdf. [PubMed]
  • 20. Extramiana F, Maison‐Blanche P, Badilini F, Beaufils P, Leenhardt A: Individual QT‐R‐R relationship: Average stability over time does not rule out an individual residual variability: Implication for the assessment of drug effect on the QT interval. Ann Noninvas Electrocardiol 2005; 10: 169–178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hondeghem LM, Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81: 686–690. [DOI] [PubMed] [Google Scholar]
  • 22. Gintant GA, Limberis JT, McDermott JS, Wegner CD, Cox BF: The canine Purkinje fiber: An in vitro model system for acquired long QT syndrome and drug‐induced arrhythmogenesis. J Cardiovasc Pharmacol 2001; 37: 607–618. [DOI] [PubMed] [Google Scholar]
  • 23. Varro A, Nakaya Y, Elharrar V, Surawicz B: Effect of antiarrhythmic drugs on the cycle length‐dependent action potential duration in dog Purkinje and ventricular muscle fibers. J Cardiovasc Pharmacol 1986; 8: 178–185. [DOI] [PubMed] [Google Scholar]
  • 24. Funck‐Brentano C, Kibleur Y, Le Coz F, Poirier JM, Mallet A, et al: Rate dependence of sotalol‐induced prolongation of ventricular repolarization during exercise in humans. Circulation 1991; 83: 536–545. [DOI] [PubMed] [Google Scholar]
  • 25. Lande G, Funck‐Brentano C, Ghadanfar M, Escande D: Steady‐state versus non‐steady‐state QT‐RR relationships in 24‐hour Holter recordings. Pacing Clin Electrophysiol 2000; 23: 293–302. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES